Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-06 04:30:32 - browse：2795

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Here’s what’s in the FDA plan to include pregnant women in clinical trials

explore

hotspot

WSS

Why don't Americans have at

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Having children helps parents live longer, especially after age 80

Change Healthcare outage fallout shows need for new oversight

EPA limits use of carcinogenic gas for sterilizing medical devices

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

knowledge

Wikipedia

Wikipedia

Hollywood unions extend contract negotiations for actors

How many hemophilia patients actually want gene therapy?

After affirmative action ruling, medical educators look to 'holistic review'

Ebola vaccine can save some who are already sick, per new study

Alkermes shareholders re

Congress considering partial increase for doctor pay in Medicare

Medicare details structure of new drug price negotiation program

Ebola vaccine can save some who are already sick, per new study

The cancer drug shortage isn’t new — and neither are the solutions

Having children helps parents live longer, especially after age 80

knowledge

FDA advisers back CAR

Latigo launches with $135 million for Vertex

Why depression after traumatic brain injury is distinct

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

John Green on his newest strategy for fighting tuberculosis

hotspot

explore

hotspot

hotspot